Security record · archived quarter
ELV
Elevance Health Inc. · Healthcare
4Tracked holders
0Δ holders
688.09KShares held
$266.91MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 688.09K | $266.91M | n/a | n/a |
| Q2 2026 | 179 | +1 | 160.45M | $61.99B | +7 | −5 |
| Q1 2026 | 180 | +5 | 158.67M | $46.48B | +9 | −5 |
| Q4 2025 | 174 | -3 | 171.19M | $60.01B | +1 | −3 |
| Q3 2025 | 26 | +3 | 90.20M | $29.15B | +4 | −2 |
| Q2 2025 | 21 | -2 | 85.20M | $33.13B | +1 | −3 |
| Q1 2025 | 20 | +1 | 41.04M | $17.85B | +2 | −1 |
| Q4 2024 | 19 | +2 | 43.15M | $15.91B | +2 | n/a |
| Q3 2024 | 16 | -2 | 27.12M | $14.09B | +1 | −3 |
| Q2 2024 | 18 | n/a | 29.21M | $15.82B | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Ninety One UK Ltd | 472.92K | -7.0% | $183.88M | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 2 | Assenagon Asset Management S.A. | 152.37K | -74.5% | $59.25M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 3 | Wealth Enhancement Advisory… | 45.76K | +34.3% | $17.28M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | TD Waterhouse Canada Inc. | 17.03K | -24.6% | $6.50M | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,453 holders, 194.60M shares, $53.66B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API